Post-Market Clinical Survey of Clareon® IOL AutonoMe™ in Japanese Subjects

NCT03824028 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 384

Last updated 2021-03-10

No results posted yet for this study

Summary

This purpose of this survey study is to collect and describe clinical outcomes for the intraocular lens (IOL) delivery performance of Clareon® IOL AutonoMe™ when used in daily practice.

Conditions

  • Cataract

Interventions

DEVICE

Clareon® IOL AutonoMe™ automated preloaded delivery system

Disposable injector preloaded with the Clareon IOL for precise IOL insertion during cataract surgery

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Alcon Research · Alcon Japan, Ltd.

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-10
Primary Completion
2020-10-20
Completion
2020-10-20

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03824028 on ClinicalTrials.gov